• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Proximal complement inhibitors in paroxysmal nocturnal hemoglobinuria: an abundance of options in a rare disease.

作者信息

White Taylor S, Arnall Justin R, Parish Paul Christopher, Tolerico Jamie, Tran Thuy, Moore Donald C

机构信息

Department of Pharmacy, Atrium Health, Levine Cancer Institute, Charlotte, NC, USA.

Department of Pharmacy, Atrium Health Specialty Pharmacy Service, Charlotte, NC, USA.

出版信息

Expert Rev Hematol. 2025 Jan;18(1):5-9. doi: 10.1080/17474086.2025.2449864. Epub 2025 Jan 6.

DOI:10.1080/17474086.2025.2449864
PMID:39754562
Abstract
摘要

相似文献

1
Proximal complement inhibitors in paroxysmal nocturnal hemoglobinuria: an abundance of options in a rare disease.阵发性睡眠性血红蛋白尿症中的近端补体抑制剂：罕见病中的众多选择
Expert Rev Hematol. 2025 Jan;18(1):5-9. doi: 10.1080/17474086.2025.2449864. Epub 2025 Jan 6.
2
The Advancing Landscape of Paroxysmal Nocturnal Hemoglobinuria Treatment.阵发性夜间血红蛋白尿治疗的进展态势
Turk J Haematol. 2025 May 22;42(2):74-81. doi: 10.4274/tjh.galenos.2025.2025.0054. Epub 2025 Apr 21.
3
Exploring treatment strategies for paroxysmal nocturnal hemoglobinuria: an overview of registered clinical trials.阵发性夜间血红蛋白尿的治疗策略探索：注册临床试验综述
Curr Med Res Opin. 2024 May 16:1-11. doi: 10.1080/03007995.2024.2354533.
4
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria.培格西他单抗在阵发性睡眠性血红蛋白尿症患者中的群体药代动力学及药代动力学/药效学分析。
Drugs R D. 2024 Dec;24(4):563-573. doi: 10.1007/s40268-024-00500-7. Epub 2024 Nov 29.
5
[New treatment strategies for paroxysmal nocturnal hemoglobinuria: the guideline update and novel complement-targeting drugs].
Rinsho Ketsueki. 2024;65(10):1303-1316. doi: 10.11406/rinketsu.65.1303.
6
Factor B inhibitor iptacopan for the treatment of paroxysmal nocturnal hemoglobinuria.因子 B 抑制剂依库珠单抗治疗阵发性睡眠性血红蛋白尿症。
Blood Rev. 2024 Jul;66:101210. doi: 10.1016/j.blre.2024.101210. Epub 2024 May 25.
7
Breakthrough hemolysis in paroxysmal nocturnal hemoglobinuria throughout clinical trials: from definition to clinical practice.阵发性夜间血红蛋白尿症在整个临床试验中的突破性溶血：从定义到临床实践
Blood. 2025 Jul 24;146(4):411-421. doi: 10.1182/blood.2024027574.
8
Current status and perspectives of hematopoietic cell transplantation in patients with paroxysmal nocturnal hemoglobinuria.阵发性睡眠性血红蛋白尿症患者造血细胞移植的现状与展望
Front Immunol. 2025 Jan 7;15:1521484. doi: 10.3389/fimmu.2024.1521484. eCollection 2024.
9
Navigating the Complement Pathway to Optimize PNH Treatment with Pegcetacoplan and Other Currently Approved Complement Inhibitors.靶向补体途径优化 PNH 治疗：培塞利珠单抗及其他已获批的补体抑制剂
Int J Mol Sci. 2024 Aug 31;25(17):9477. doi: 10.3390/ijms25179477.
10
Three Years On: The Role of Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria (PNH) since Its Initial Approval.三年随访：培戈洛珠单抗在阵发性睡眠性血红蛋白尿症（PNH）初始获批后的作用。
Int J Mol Sci. 2024 Aug 9;25(16):8698. doi: 10.3390/ijms25168698.

引用本文的文献

1
Viral infections and related fatal adverse events associated with complement inhibitors for PNH: a real-world pharmacovigilance analysis in FAERS.阵发性睡眠性血红蛋白尿症补体抑制剂相关的病毒感染及相关致命不良事件：基于FAERS的真实世界药物警戒分析
Front Pharmacol. 2025 Aug 11;16:1639685. doi: 10.3389/fphar.2025.1639685. eCollection 2025.